QNCX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 23:39):

Stats
今日成交量	11 826.00
平均成交量	70 732.00
市值	45.58M
EPS	$0 ( 2024-04-02 )
下一个收益日期	( $0 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.260
ATR14	$0.00500 (0.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-15	Patni Rajiv	Buy	54 000	Employee Stock Option (right to buy)
2024-02-15	Patni Rajiv	Buy	0
2024-02-01	Ryan Charles S.	Buy	145 000	Employee Stock Option (right to buy)
2024-02-01	Hannah Brendan	Buy	600 000	Employee Stock Option (right to buy)
2024-02-01	Thye Dirk	Buy	1 500 000	Employee Stock Option (right to buy)

INSIDER POWER
90.02
Last 72 transactions
Buy: 5 607 188 \| Sell: 249 899

音量相关性

長: -0.12 (neutral)

短: 0.92 (very strong)

Signal:(46.737) Expect same movement, but be aware

Quince Therapeutics, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Quince Therapeutics, Inc. 相关性 - 货币/商品

0.02
( neutral )

0.12
( neutral )

0.00
( neutral )

-0.42
( neutral )

0.04
( neutral )

Quince Therapeutics, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2023
营收:	$0
毛利润:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2022
营收:	$0
毛利润:	$-175 000 (0.00 %)
EPS:	$-1.540

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-3.02

Financial Reports:

No articles found.

Quince Therapeutics, Inc.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.